DIH Group - DHAI Enterprise Value to EBITDA Ratio
DIH Holding US, Inc. (DHAI) develops automated systems and exoskeletons for patient rehabilitation, minimizing the need for manual labor by therapists. Assembly plants are located in China, Germany, and the Netherlands, which streamlines the global delivery of equipment. This daily price chart, featuring the indicator, highlights the dependence of this niche business on the investment capabilities of medical centers, despite its global reach.
Comprehensive metric breakdowns and analytics for DIH Holding US Inc. (DHAI)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital DIH Holding US, Inc.|DHAI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio DIH Holding US Inc.|DHAI - Aggregate Debt Obligations|Debts to Book Capitalization DIH Holding US, Inc.|DHAI - Company Long-Term Loans and Borrowings|Company Short-Term Debt DIH Holding|Quick Liquidity dih.com
- financial results and valuation multiples details:
DHAI - Company Net Income|Projected Future Earnings DIH Holding US, Inc.|DHAI - Price to Earnings Multiple|Forward P/E Multiple DIH Holding US|DHAI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DIH Holding US Inc.|DHAI - Operating profit before amortization|Net earnings per share (EPS TTM) DIH Holding|DHAI - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months dih.com|DHAI - Earnings per share increase in current year|Expected earnings per share growth for next year DIH Holding US, Inc.
- sales and revenue indicators:
Summary company analysis:DIH Holding US, Inc. DHAI
The global expansion of DIH Holding US, Inc. (DHAI) in the field of medical robotics requires significant capital expenditures and debt load management. This indicator compares the total enterprise value with operating profit before depreciation, taxes, and interest, determining the real value of assets relative to their yield. Analyzing the EV/EBITDA ratio while accounting for financial leverage allows investors to assess the resilience of the company's balance sheet against regulatory risks across various markets.
Key competitors
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Healthcare Corporation)|Fresenius Medical Care - EV/EBITDA Multiple|Solventum Corp - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation UHS|Enterprise Value to EBITDA Ratio DVA|EV/EBITDA Multiple RadNet, Inc.|Enterprise Value to EBITDA Ratio OPCH (Option Care Health)|SGRY (Surgery Partners) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier Health PINC|America's Best Contacts & Eyeglasses (EYE) - Company Value to EBITDA|PGNY: Enterprise Value to EBITDA Ratio|ARDT (Ardent Health Partners) - Enterprise Value to Operating Income Before Depreciation|SEM (Select Medical Holdings) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation ASTH|Enterprise Value to EBITDA Ratio MD|USPH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Pennant Group (PNTG)|ORGO - Company Value to EBITDA|EV/EBITDA Multiple NUTX (nutexhealth.com)|EV/EBITDA Multiple Auna S.A. AUNA|SBC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Evolus, Inc. (EOLS) - Enterprise Value to EBITDA Ratio|CYH: EV/EBITDA Multiple|The Beauty Health Company - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio MDWD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BTMD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Joint Corporation (JYNT)|DocGo, Inc (DCGO) - Enterprise Value to EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation Ratio P3 Health (PIII)|Enterprise Value to Operating Income Before Depreciation Ratio GANX (Gain Therapeutics)|EUDA Health Holdings - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Basel Medical Group Ltd (BMGL)|CLGN: EV/EBITDA Multiple|CUPR - Total Company Value to Operating Income Before Depreciation Ratio|CCM (Concord Medical Services Holdings) - EV/EBITDA Multiple|Company Value to EBITDA ashs.com AMS|Enterprise Value to EBITDA Ratio MRM (MEDIROM)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ALBT (Avalon GloboCare Corp.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carmellcosmetics.com XAGE|NIVF - Enterprise Value to EBITDA Ratio|ATIP: Enterprise Value to EBITDA Ratio|CMAX - EV/EBITDA Multiple|KDLY: EV/EBITDA Multiple|Company Value to EBITDA ModivCare (MODV)|NVOS (Novo Integrated Sciences Corp) - EV/EBITDA Multiple|sunlinkhealth.com (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
